Quick Takeaways
- HBM Healthcare Investments (Cayman) Ltd. filed SCHEDULE 13G/A for IO Biotech, Inc. Common Stock, par value $0.001 per share (IOBT).
- Disclosed ownership: 3.3%.
- Date of event: 02 Apr 2026.
HBM Healthcare Investments (Cayman) Ltd. - 02 Apr 2026 SCHEDULE 13G/A Report for IO Biotech, Inc. Common Stock, par value $0.001 per share (IOBT)
- Filing Manager
- HBM Healthcare Investments (Cayman) Ltd.
- Reporting Manager
- HBM Healthcare Investments (Cayman) Ltd.
- Symbol
- IOBT
- Shares outstanding
- 73,755,848 shares
- Disclosed Ownership
- 2,433,943 shares
- Ownership
- 3.3%
- Form type
- SCHEDULE 13G/A
- Filing time
- 06 Apr 2026, 16:05:28 UTC
- Date of event
- 02 Apr 2026
- Previous filing
- 13 Feb 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"HBM Healthcare Investments (Cayman) Ltd. disclosed 3.3% ownership in IO Biotech, Inc. Common Stock, par value $0.001 per share (IOBT) on 02 Apr 2026."
What Changed
- Previous schedule filing date: 13 Feb 2025.
- Current filing was accepted on 06 Apr 2026, 16:05.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| HBM Healthcare Investments (Cayman) Ltd. | 3.3% | 2,433,943 | 2,433,943 | 0 | /s/ Jean-Marc LeSieur | Jean-Marc LeSieur, Managing Director |